Vanguard Group Inc Caribou Biosciences, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,110,795 shares of CRBU stock, worth $6.74 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,110,795
Previous 3,962,044
3.75%
Holding current value
$6.74 Million
Previous $22.7 Million
6.93%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding CRBU
# of Institutions
158Shares Held
67.4MCall Options Held
111KPut Options Held
105K-
Black Rock Inc. New York, NY7.01MShares$11.5 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA6.48MShares$10.6 Million1.64% of portfolio
-
State Street Corp Boston, MA6.35MShares$10.4 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX5.79MShares$9.49 Million1.15% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.59MShares$5.88 Million0.05% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $99.8M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...